Medical News

RSS

Nevro gets FDA approval letter for Senza spinal cord stimulation system

Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received a letter from the U.S. Food and Drug Administration informing the company of the approvability of its Premarket Approval Application (PMA) for the Senza spinal cord stimulation (SCS) system.

23 Jan 2015

Alexza begins Phase 2a study of AZ-002 for ARS-related epilepsy management

Alexza Pharmaceuticals, Inc. announced today that it has initiated a Phase 2a study of AZ-002 (Staccato alprazolam), which is being developed for the management of epilepsy in patients with acute repetitive seizures (ARS).

22 Jan 2015

Kaiser Permanente, NBA form strategic partnership to build healthier communities

Kaiser Permanente and the National Basketball Association announced today a new multiyear strategic partnership that will focus on building healthier communities. The agreement also makes Kaiser Permanente the Official Health Care Partner of the NBA, Women's National Basketball Association, NBA Development League, and USA Basketball.

22 Jan 2015

EPIC's Hearing Health Plan receives Health Network Accreditation from URAC

EPIC Hearing Healthcare announced today that its Hearing Health Plan has been awarded the Health Network Accreditation from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

22 Jan 2015

Innovent Biologics raises $100 million in Series C financing

Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.

22 Jan 2015

Gastroenterology publishes landmark data from RESPECT study of Transoral Incisionless Fundoplication procedure

EndoGastric Solutions announces that Gastroenterology, the official journal of the American Gastroenterological Association Institute and the most prominent journal in the field of gastrointestinal disease, has published landmark data from the first-ever blinded, randomized, sham- and placebo-controlled clinical study of the Transoral Incisionless Fundoplication (TIF) procedure.

22 Jan 2015

Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

Cypher Genomics, Inc., the leading genome informatics company, and Sequenom, Inc., the leading molecular diagnostics company, today announced a development agreement for next generation noninvasive prenatal tests (NIPT).

22 Jan 2015

Gensignia's research in CT lung cancer screening recognized by ASCO

Gensignia scientific co-founders' research has been recognized in Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology published online in the Journal of Clinical Oncology (JCO) on January 20, 2015.

22 Jan 2015

DePuy Synthes announces launch of new CMF MatrixWAVE MMF System

The DePuy Synthes Companies of Johnson & Johnson today announced the launch of the DePuy Synthes CMF MatrixWAVE MMF System, an adaptable wave-patterned bone borne plate and screw system designed for use in the temporary stabilization of mandibular and maxillary fractures and osteotomies.

22 Jan 2015

K2M obtains FDA approval to market MESA 2 Deformity Spinal System

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market the MESA 2 Deformity Spinal System.

22 Jan 2015

USC neuroscientists find potential prevention for Alzheimer's disease

University of Southern California neuroscientists may have unlocked another puzzle to preventing risks that can lead to Alzheimer's disease. Researchers at Keck Medicine of USC used high-resolution imaging of the living human brain to show for the first time that the brain's protective blood barrier becomes leaky with age, starting at the hippocampus, a critical learning and memory center that is damaged by Alzheimer's disease.

22 Jan 2015

Taking hormonal contraceptives for five years doubles brain tumour risk

Taking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumour, glioma of the brain. This project focussed on women aged 15 -49 years and the findings are published in the British Journal of Clinical Pharmacology.

22 Jan 2015

NCCS launches human clinical trial of new cancer vaccine

The National Cancer Centre Singapore has launched a clinical trial of a new cancer vaccine administered to human patients for the first time in the world. Cancer immunotherapy (the harnessing of the body's defence system to fight the patient's cancer, has emerged as one of the most exciting medical breakthroughs in the past two years.

22 Jan 2015

Study identifies gene that may become resistant to current testicular cancer treatments

A major research study has uncovered several new genetic mutations that could drive testicular cancer - and also identified a gene which may contribute to tumours becoming resistant to current treatments.

22 Jan 2015

Researchers reveal role of epigenetic factors in malignant skin cancer

Melanoma, the most aggressive of all skin cancer strains, is often fatal for patients due to the pronounced formation of metastases. Until now, a melanoma's rampant growth was mainly attributed to genetic causes, such as mutations in certain genes. However, researchers from the University of Zurich now reveal that so-called epigenetic factors play a role in the formation of metastases in malignant skin cancer. This opens up new possibilities for future cancer treatments.

22 Jan 2015

OUP publishes first issue of ESC's European Heart Journal - Cardiovascular Pharmacotherapy

Oxford University Press is delighted to announce the publication of the first issue of European Heart Journal - Cardiovascular Pharmacotherapy (EHJCVP), which it is publishing on behalf of the European Society for Cardiology and the Working Group on Cardiovascular Pharmacotherapy.

22 Jan 2015

Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, announces significant progress in its drug discovery collaboration with AstraZeneca.

22 Jan 2015

INRS researchers to use new specialized equipment to study environmental equity, male infertility

With the acquisition of new specialized equipment, INRS researchers Philippe Apparicio, Géraldine Delbès, and Maritza Jaramillo and their teams will be able to advance knowledge and train highly qualified people in the fields of environmental equity, reproductive toxicology, and the treatment of infections. They received a total of over $1 million from the Quebec government and the John R. Evans Leaders Fund of the Canadian Foundation for Innovation.

22 Jan 2015

New article provides insight into cognitive fatigue in people with multiple sclerosis

Kessler Foundation researchers have authored a new article that provides insight into the factors that contribute to cognitive fatigue in individuals with multiple sclerosis (MS). The article, "Subjective cognitive fatigue in MS depends on task length," was epublished ahead of print on October 27 in Frontiers in Neurology.

22 Jan 2015

LSU Health New Orleans researcher discovers fragment of toxic Ebola virus protein

William Gallaher, PhD, Emeritus Professor of Microbiology, Immunology & Parasitology at LSU Health New Orleans School of Medicine, has discovered a fragment of an Ebola virus protein that is toxic to cells and may contribute to infection and illness.

22 Jan 2015

Medical News

Nevro gets FDA approval letter for Senza spinal cord stimulation system

Alexza begins Phase 2a study of AZ-002 for ARS-related epilepsy management

Kaiser Permanente, NBA form strategic partnership to build healthier communities

EPIC's Hearing Health Plan receives Health Network Accreditation from URAC

Innovent Biologics raises $100 million in Series C financing

Gastroenterology publishes landmark data from RESPECT study of Transoral Incisionless Fundoplication procedure

Cypher Genomics, Sequenom sign development agreement for noninvasive prenatal tests

Gensignia's research in CT lung cancer screening recognized by ASCO

DePuy Synthes announces launch of new CMF MatrixWAVE MMF System

K2M obtains FDA approval to market MESA 2 Deformity Spinal System

USC neuroscientists find potential prevention for Alzheimer's disease

Taking hormonal contraceptives for five years doubles brain tumour risk

NCCS launches human clinical trial of new cancer vaccine

Study identifies gene that may become resistant to current testicular cancer treatments

Researchers reveal role of epigenetic factors in malignant skin cancer

OUP publishes first issue of ESC's European Heart Journal - Cardiovascular Pharmacotherapy

Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

INRS researchers to use new specialized equipment to study environmental equity, male infertility

New article provides insight into cognitive fatigue in people with multiple sclerosis

LSU Health New Orleans researcher discovers fragment of toxic Ebola virus protein

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News